About Modella
Modella is a Technology company based in Boston (United States) founded in 2024 by Jill Stefanelli, and was acquired by Astrazeneca in January 2026. It develops AI models for pathology diagnostics and biomedical image analysis. It operates on a B2B and SaaS model. Its chief executive, as recorded, is Jill Stefanelli. Its website modella.ai draws about 11 thousand monthly visits. Modella offers products and services including PathChat and Judith. Its focus areas include AI Development, Biomedical Applications, Model Automation and Healthcare. Its competitors include PathAI, Deepcell and Pictor Labs; 3 of its 3 listed competitors have raised funding.
Company details
Modella AI is a biomedical AI company based in Boston, Massachusetts, focusing on creating innovative AI models that integrate multimodal data for pathology diagnostics and therapeutic workflows. They offer products like PathChat, an AI copilot for summarizing pathology reports, and Judith, a tool for automating AI development in biomedical image analysis. The interdisciplinary team of scientists and clinicians works to enhance healthcare outcomes through advanced AI applications.
- Headquarters Boston, United States
- Founders Jill Stefanelli
- Stage Acquired
- SectorsTechnology
- Email••••••••
- Website modella.ai
- Social LinkedIn X
- Acquired by Astrazeneca (Jan 2026)
- Investors
- Acquired byAstrazeneca
(Jan 2026)
Products & Services of Modella
Modella offers a comprehensive portfolio of products and services, including PathChat and Judith.
AI tool for summarizing and creating pathology reports.
Platform for automating AI models in biomedical analysis.
Investors in Modella
Modella has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Astrazeneca.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical and biologics products are developed and distributed worldwide. | 1913 | astrazeneca.com | Cambridge, United Kingdom |
Investor details for Modella
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Modella
1 people are tracked at Modella (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jill Stefanelli | Co-Founder, Chief Executive Officer | Leadership |
Complete people profiles for Modella
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Modella
2 dated milestones of Modella across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Modella is founded.
- Exit Acquired by Astrazeneca.
Competitors of Modella
Modella has 3 listed competitors in our database, 3 of them funded. They include PathAI, Deepcell and Pictor Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research | |
| pictorlabs.ai | 2019 | Los Angeles, United States | $48.83M | AI-based tools for pathological image analysis are provided to labs. |
Detailed competitors of Modella
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Modella
The website of Modella (modella.ai) receives about 11.2K visits a month.
- Monthly visits11.2K
▲ 70.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Modella
Modella was founded in 2024.
Modella is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Jill Stefanelli is the CEO of Modella, as recorded in our data. They have also founded this company.
Modella AI is a biomedical AI company based in Boston, Massachusetts, focusing on creating innovative AI models that integrate multimodal data for pathology diagnostics and therapeutic workflows. They offer products like PathChat, an AI copilot for summarizing pathology reports, and Judith, a tool for automating AI development in biomedical image analysis. The interdisciplinary team of scientists and clinicians works to enhance healthcare outcomes through advanced AI applications.
Modella's top competitors include Pictor Labs, PathAI and Deepcell.
Modella offers PathChat and Judith.
Modella has 1 investor. Key investors include Astrazeneca.
Yes. Modella was acquired by Astrazeneca in January 2026.